Search
Genelux Corp
GNLXAdd to Watchlist
2.890USD
-0.030-1.03%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
128.34MMarket Cap
LossP/E TTM
Genelux Corp's Company Valuation
Currency: USD Updated: 2026-06-22The current valuation score of Genelux Corp is 6.10, ranking 360 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.43, which is -49.87% below the recent high of -1.72 and -1474.37% above the recent low of -53.93.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
